These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29568275)

  • 1. Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.
    Cai H; Cao T; Zhou X; Yao JK
    Front Psychiatry; 2018; 9():73. PubMed ID: 29568275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.
    Cai H; Zhou X; Dougherty GG; Reddy RD; Haas GL; Montrose DM; Keshavan M; Yao JK
    Psychoneuroendocrinology; 2018 Apr; 90():43-51. PubMed ID: 29433072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence.
    Marx CE; Bradford DW; Hamer RM; Naylor JC; Allen TB; Lieberman JA; Strauss JL; Kilts JD
    Neuroscience; 2011 Sep; 191():78-90. PubMed ID: 21756978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.
    Marecki R; Kałuska J; Kolanek A; Hakało D; Waszkiewicz N
    Front Psychiatry; 2023; 14():1298359. PubMed ID: 38116383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosteroids: A potential target for neuropsychiatric disorders.
    Wang M; Hu S; Fu X; Zhou H; Yang S; Yang C
    J Steroid Biochem Mol Biol; 2024 May; 239():106485. PubMed ID: 38369032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.
    Reddy DS; Kulkarni SK
    Psychopharmacology (Berl); 1998 Jun; 137(4):391-400. PubMed ID: 9676900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.
    Reddy DS
    J Neuroendocrinol; 2022 Feb; 34(2):e13028. PubMed ID: 34506047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia.
    Ritsner MS
    Neuroscience; 2011 Sep; 191():91-100. PubMed ID: 21549182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of neurosteroids in a rodent model of primary paroxysmal dystonia.
    Hamann M; Richter F; Richter A
    Horm Behav; 2007 Aug; 52(2):220-7. PubMed ID: 17553499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroids and potential therapeutics: Focus on pregnenolone.
    Vallée M
    J Steroid Biochem Mol Biol; 2016 Jun; 160():78-87. PubMed ID: 26433186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A role of neurosteroids in the pathogenesis of psychiatric disorders].
    Petelin DS; Bairamova SP; Akhapkin RV; Kudryashov NV; Sorokina OY; Semin SA; Volel BA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(4):31-36. PubMed ID: 37084362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical potentials of endogenous neurosteroids.
    Reddy DS
    Drugs Today (Barc); 2002 Jul; 38(7):465-85. PubMed ID: 12582464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between neurosteroid and endocannabinoid systems in cannabis addiction.
    Raux PL; Vallée M
    J Neuroendocrinol; 2023 Feb; 35(2):e13191. PubMed ID: 36043319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic avenues for neurosteroids in psychiatric diseases].
    Froger N
    Biol Aujourdhui; 2019; 213(3-4):131-140. PubMed ID: 31829933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging evidence for endogenous neurosteroid modulation of pro-inflammatory and anti-inflammatory pathways that impact neuropsychiatric disease.
    Morrow AL; Boero G; Balan I
    Neurosci Biobehav Rev; 2024 Mar; 158():105558. PubMed ID: 38244954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relating neurosteroid modulation of inhibitory neurotransmission to behaviour.
    Belelli D; Phillips GD; Atack JR; Lambert JJ
    J Neuroendocrinol; 2022 Feb; 34(2):e13045. PubMed ID: 34644812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.
    Ritsner MS
    CNS Neurosci Ther; 2010; 16(1):32-44. PubMed ID: 20070787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs.
    Barbaccia ML
    Crit Rev Neurobiol; 2004; 16(1-2):67-74. PubMed ID: 15581401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosteroids and behavior.
    Engel SR; Grant KA
    Int Rev Neurobiol; 2001; 46():321-48. PubMed ID: 11599304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.
    Marx CE; Lee J; Subramaniam M; Rapisarda A; Bautista DC; Chan E; Kilts JD; Buchanan RW; Wai EP; Verma S; Sim K; Hariram J; Jacob R; Keefe RS; Chong SA
    Psychopharmacology (Berl); 2014 Sep; 231(17):3647-62. PubMed ID: 25030803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.